Hydrolethalus syndrome
Hydrolethalus syndrome (HLS) is a rare genetic disorder characterized by severe congenital malformations that are typically lethal in the neonatal period. The syndrome is inherited in an autosomal recessive manner and is most commonly reported in the Finnish population.
Clinical Features[edit | edit source]
Individuals with Hydrolethalus syndrome present with a range of severe abnormalities, including:
- Hydrocephalus: An abnormal accumulation of cerebrospinal fluid within the brain.
- Polydactyly: The presence of extra fingers or toes.
- Cleft lip and palate: A split in the upper lip and/or the roof of the mouth.
- Micrognathia: An unusually small jaw.
- Central nervous system malformations: Including holoprosencephaly, where the brain fails to divide properly into two hemispheres.
Genetics[edit | edit source]
Hydrolethalus syndrome is caused by mutations in the HYLS1 gene, which is located on chromosome 11. The HYLS1 gene is involved in the development of the ciliary body, which is essential for normal embryonic development.
Diagnosis[edit | edit source]
Diagnosis of Hydrolethalus syndrome is typically made through prenatal ultrasound findings and confirmed by genetic testing. The presence of characteristic malformations on ultrasound can prompt further genetic analysis to identify mutations in the HYLS1 gene.
Management[edit | edit source]
There is no cure for Hydrolethalus syndrome, and management is primarily supportive. Due to the severity of the malformations, most affected infants do not survive beyond the neonatal period. Prenatal diagnosis allows for informed decision-making by the parents.
Epidemiology[edit | edit source]
Hydrolethalus syndrome is most commonly reported in the Finnish population, where it has a higher incidence due to a founder effect. However, cases have been reported in other populations as well.
See Also[edit | edit source]
- Genetic disorder
- Autosomal recessive
- Hydrocephalus
- Polydactyly
- Cleft lip and palate
- Micrognathia
- Holoprosencephaly
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD